As illustrated by Lesina et al (2011), Zhang et al (2013), IL‐6 is required during PDA progression, and we have demonstrated that fibroblasts are a major source of IL‐6 in the tumor microenvironment. The gene discussed is IL6; the disease is Patent ductus arteriosus.